The FDA’s Pazdur on accelerated approval, single-arm studies, and his own future
Adam Feuerstein (Senior Writer, STAT) published the article, “The FDA’s Pazdur on accelerated approval, single-arm studies, and his own future” on 4 June 2022. To read the full article,CLICK HERE
CDDF: Announcement of Newly Elected Leadership
The Cancer Drug Development Forum Announces Newly Elected Leadership The Cancer Drug Development Forum (CDDF) is delighted to announce newly elected leadership, appointed at its General Assembly on 1 June 2022. Please join us in welcoming former...
CDDF Annual Report 2021
The CDDF has published its 2021 annual report which highlights the steps the association has taken to further its mission in the year in order to stimulate advancement in cancer drug development and access. To read the report, click the following link: CDDF Annual...